Alexander Cumbo's Net Worth
$13.3 Million
Who is Alexander Cumbo?
Alexander Cumbo has an estimated net worth of $13.3 Million. This is based on reported shares across multiple companies, which include Sarepta Therapeutics, Inc., Ra Pharmaceuticals, Inc., Verve Therapeutics, Inc., and Solid Biosciences Inc..
SEC CIK
Alexander Cumbo's CIK is 0001685994
Past Insider Trading and Trends
2018 was Alexander Cumbo's most active year for acquiring shares with 10 total transactions. Alexander Cumbo's most active month to acquire stocks was the month of February. 2018 was Alexander Cumbo's most active year for disposing of shares, totalling 17 transactions. Alexander Cumbo's most active month to dispose stocks was the month of February. 2019 saw Alexander Cumbo paying a total of $944,266.78 for 105,082 shares, this is the most they've acquired in one year. In 2019 Alexander Cumbo cashed out on 102,746 shares for a total of $7,627,942.20, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Sarepta Therapeutics, Inc. (SRPT) Snapshot price: $128.92
EVP, Chief Commercial Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +358.86% | 6.7K |
—
|
—
| 8.57K |
Feb 28
| |||
Form 4
| -83.27% | -9.29K |
$74.60 | -$4,495,768.22 | 1.87K |
Scheduled
|
Dec 13
| ||
Form 4
| +32.08% | 2.71K |
$118.68 | -$256,942.20 | 11.16K |
Mar 28
| |||
Form 4
| -28.54% | -3.38K |
—
|
—
| 8.45K |
Feb 28 - Mar 4
| |||
Form 4
| -32.94% | -7.50K |
$81.27 | -$1,930,965.00 | 15.27K |
Scheduled
|
Feb 1
| ||
Form 4
| -20.86% | -6.00K |
$121.02 | -$726,120.00 | 22.77K |
Aug 8
| |||
Form 4
|
—
|
0
|
$75.55 | -$4,173,529.36 | 28.77K |
Scheduled
|
Jul 9
| ||
Form 4
| +13.59% | 3.44K |
$89.22 | -$128,030.70 | 28.77K |
May 22
| |||
Form 4
| +7.96% | 1.87K |
$50.93 | $187.49 | 25.32K |
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 5
| |||
Form 4
| +39.01% | 6.58K |
$37.88 | -$120,041.72 | 23.46K |
Aug 3
| |||
Form 4
| -16.84% | -3.42K |
$27.36 | -$208,363.00 | 16.88K |
Scheduled
|
Jul 20
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ra Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Nov 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Verve Therapeutics, Inc. (VERV) Snapshot price: $5.595
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Solid Biosciences Inc. (SLDB) Snapshot price: $8.11
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 13
| |||
Form 4
| +2,886.13% | 16.86K |
$2.77 | -$32,516.33 | 17.44K |
Dec 2 - Dec 4
| |||
Form 4
|
∞
| 584 |
—
|
—
| 584 |
Dec 2
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||